Sustained release formulation comprising bisphosphonate

Details Sustained release formulation comprising bisphosphonate Sustained release formulation comprising bisphosphonate

A - Human Necessities

61

K

A61K 9/08 (2006.01) A61K 47/12 (2006.01) A61K 47/18 (2006.01) A61P 5/02 (2006.01)

Patent

CA 2585116

A pharmaceutical composition for parenteral administration of a somatostatin analogue salt of aspartate, e.g. mono- or diaspartate, lactate, succinate, e.g. mono- or disuccinate, acetate, glutamate, e.g. mono- or diglutamate or citrate and water forming a gelling depot system after injection in contact with the body fluid.

La présente invention concerne une composition pharmaceutique destinée à l'administration parentérale d'un sel analogue de la somatostatine, à l'état aspartate (mono- ou diaspartate), lactate, succinate (mono- ou disuccinate), acétate, glutamate (mono- ou diglutamate) citrate, et d'un système hydrique formant dépôt en gel après injection au contact du fluide anatomique.

Affiliated with

Also associated with

Rating

Sustained release formulation comprising bisphosphonate does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained release formulation comprising bisphosphonate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release formulation comprising bisphosphonate will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1412833